Tumor targeting units are disclosed which have a peptide sequence C
y
—Y—G-F—X—W-G-Z-C
yy
(SEQ ID NO: 25), or a pharmaceutically or physiologically acceptable salt thereof. Tumor targeting agents are also disclosed having at least one targeting unit, directly or indirectly coupled to at least one effector unit. Diagnostic or pharmaceutical compositions having at least one targeting unit or at least one targeting agent, and targeting units or targeting agents for the preparation of a medicament for the treatment of cancer related diseases (including cancer), especially for the treatment of colon/colorectal cancer or its metastases are also disclosed.
PETTER, RUSSELL C.;BANERJEE, SATYAJIT;ENGLARD, SASHA, J. ORG. CHEM., 55,(1990) N0, C. 3088-3097
作者:PETTER, RUSSELL C.、BANERJEE, SATYAJIT、ENGLARD, SASHA
DOI:——
日期:——
[EN] DIAGNOSTIC AND THERAPEUTIC AGENTS<br/>[FR] AGENTS DIAGNOSTIQUES ET THÉRAPEUTIQUES
申请人:KARYON CTT LTD
公开号:WO2007113385A1
公开(公告)日:2007-10-11
[EN] The present invention relates to tumor targeting units comprising a peptide sequence Cy-Y-G-F-X-W-G-Z-Cyy, or a pharmaceutically or physiologically acceptable salt thereof. The invention further relates to tumor targeting agents comprising at least one targeting unit according to the present invention, directly or indirectly coupled to at least one effector unit. The present invention further relates to diagnostic or pharmaceutical compositions comprising at least one targeting unit or at least one targeting agent according to the present invention, and to the use of targeting units or targeting agents according to the present invention for the preparation of a medicament for the treatment of cancer or cancer related diseases, especially for the treatment of colon/colorectal cancer or its metastases. [FR] La présente invention concerne des unités de ciblage de tumeurs comprenant une séquence peptide C y - Y - G - F - X - W - G - Z - Cyy, ou un sel pharmaceutiquement ou physiologiquement acceptable de celle-ci. L'invention concerne en outre des agents de ciblage de tumeurs comprenant au moins une unité de ciblage selon la présente invention, couplée directement ou indirectement à au moins une unité effectrice. La présente invention a pour objet en outre des compositions diagnostiques ou pharmaceutiques qui comprennent au moins une unité de ciblage ou au moins un agent de ciblage selon la présente invention, et d'utiliser des unités de ciblage ou des agents de ciblage selon la présente invention pour la préparation d'un médicament pour le traitement de cancer ou de maladies cancéreuses, en particulier pour le traitement de cancer du colon/du cancer colorectal ou de leurs métastases.
Inhibition of .gamma.-butyrobetaine hydroxylase by cyclopropyl-substituted .gamma.-butyrobetaines
作者:Russell C. Petter、Satyajit Banerjee、Sasha Englard